• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, February 9, 2024


Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Articles in Medriva and Becker’s Payer Issues referenced a study published in the February 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans,” found that calling patients at the time of enrollment in a health plan could help in collecting health literacy data.

A piece by PharmExec referenced an article published by AJMC’s sister site, The Center for Biosimilars®. The article, “Why Pharmacovigilance Is Important for Biosimilars,” emphasized the need for constant pharmacovigilance among clinicians due to how many factors can affect the quality and performance of biosimilars.

Related Videos
Video 2 - "Exploring Therapies for Platinum Sensitive & Platinum-Resistant Ovarian Cancer"
Imran Khan, MD, PhD, Johnson & Johnson
ateyeh soroush
dr kathy zackowski
dr mitzi joi williams
Related Content
© 2024 MJH Life Sciences
All rights reserved.